ReviewFEMS microbiology reviews2025
Engineering microorganisms for enhanced tolerance to toxic end-products and intermediates.
Review in FEMS microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Microbial manufacturing offers a sustainable and environmentally friendly approach for chemical production. However, the inherent toxicity of certain high-value chemicals to microbial cell factories presents a significant challenge, severely constraining production efficiency. To enhance microbial tolerance, extensive synthetic biology strategies have been developed. The cell envelope serves as the primary natural barrier in microorganisms, and both its intrinsic composition, including membrane lipids, membrane proteins, and cell wall components, and the regulation of these components play crucial roles in modulating cellular responses to environmental stress. Engineering strategies targeting intracellular components, such as transcription factors and repair pathways, have demonstrated effectiveness in enhancing microbial tolerance to toxic end-products and intermediates. Additionally, recent advances have focused on extracellular engineering, including biofilm formation and the modulation of intercellular interactions, which have garnered significant scientific interest. This review aims to provide a systematic overview of these strategies and offers insights to facilitate the industrial translation and commercialization of microbial production of toxic end-products and intermediates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.